GLP-1 Medications for Weight Loss Now Available!

The state of Louisiana currently has 2 active clinical trials seeking participants for Weight Loss research studies. These trials are conducted in various cities, including New Orleans, Baton Rouge, Shreveport and Metairie.
VK2735 for Weight Management Phase 2 (Venture Oral Dosing)
Recruiting
This is a phase 2, 13-week randomized, double-blind, placebo-controlled, parallel arm dose-finding study that will evaluate the safety, tolerability, weight loss efficacy, pharmacodynamic effects, and pharmacokinetics of VK2735 Oral Formulation in adults who are obese (BMI ≥30 kg/m2) or who are overweight (BMI ≥27 kg/m2) with at least one weight-related co-morbid condition. VK2735 or matched placebo will be administered once daily.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/19/2025
Locations: Viking Clinical Site #114, Marrero, Louisiana
Conditions: Weight Loss
International Weight Control Registry
Recruiting
The IWCR is a global scientific study aimed at better understanding the opportunities and barriers for reducing the prevalence of obesity by collecting information from people who have experience with weight management in their everyday lives. The investigators seek to gather information on a wide range of weight management experiences, ranging from weight loss and weight loss maintenance to weight gain and inability to lose weight.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/03/2024
Locations: Pennington Biomedical Research Center, Baton Rouge, Louisiana
Conditions: Weight Loss, Overweight, Obesity